/Companies

Cerebral Therapeutics

Aurora, US · Delaware corporation · 4 known investors

Find your way into Cerebral Therapeutics

Sign up to see every warm intro you have to Cerebral Therapeutics

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Cerebral Therapeutics team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Founders & leadership

DA
Daniel AbramsChief Executive Officer
WLWarren Lammert
Warren LammertChairman2018–2020Founder at Tevard Biosciences
SF
Stephen FarrNamed on SEC filing
MS
Mahendra ShahNamed on SEC filingSenior Fellow at Vivo Capital

Investors · 4

Granite Point Capitalreported

How we know: funding news · press coverage · Not right? Tell us

March Capital PartnersreportedSanta Monica

How we know: a partner's Signal profile · Not right? Tell us

RA CapitalreportedBoston

How we know: funding news · press coverage · Not right? Tell us

Vivo CapitalreportedPalo Alto · $10M – $50M

How we know: a partner's Signal profile · funding news · press coverage · Not right? Tell us

Funding

SEC filings, press & company announcements

$71M disclosed across 3 rounds · 2018–2022

▶$20MraisedJan 2020 · 6 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Daniel AbramsExecutive Officer, Director
  • Shah MahendraDirector
  • Warren LammertDirector
  • Stephen FarrDirector
  • Weston NicholsDirector
  • Matthew HammondDirector
Offering amount
$35M
Amount sold
$20M
First sale
Jan 2020
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$11MraisedMar 2019 · 4 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Warren LammertDirector
  • Stephen FarrDirector
  • Mahendra ShahDirector
  • Daniel AbramsExecutive Officer, Director
Offering amount
$11M
Amount sold
$11M
First sale
Jun 2018
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

Who are Cerebral Therapeutics's investors?
Cerebral Therapeutics's investors include Granite Point Capital, March Capital Partners, RA Capital, Vivo Capital.
How much funding has Cerebral Therapeutics raised?
Cerebral Therapeutics has disclosed $71M raised across 3 rounds.
Where is Cerebral Therapeutics headquartered?
Cerebral Therapeutics is headquartered in Aurora, US.